Taiwan
· Delayed Price · Currency is TWD Locus Cell Statistics
Total Valuation
Locus Cell has a market cap or net worth of TWD 4.67 billion. The enterprise value is 3.32 billion.
| Market Cap | 4.67B |
| Enterprise Value | 3.32B |
Important Dates
The next estimated earnings date is Friday, April 11, 2025.
| Earnings Date | Apr 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Locus Cell has 200.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 200.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.70% |
| Owned by Institutions (%) | 0.02% |
| Float | 72.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.63 |
| P/TBV Ratio | 2.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -30.38 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.38 |
Financial Position
The company has a current ratio of 16.50, with a Debt / Equity ratio of 0.04.
| Current Ratio | 16.50 |
| Quick Ratio | 16.17 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.18 |
| Interest Coverage | -123.13 |
Financial Efficiency
Return on equity (ROE) is -5.98% and return on invested capital (ROIC) is -5.10%.
| Return on Equity (ROE) | -5.98% |
| Return on Assets (ROA) | -4.99% |
| Return on Invested Capital (ROIC) | -5.10% |
| Return on Capital Employed (ROCE) | -8.45% |
| Revenue Per Employee | 31,515 |
| Profits Per Employee | -3.31M |
| Employee Count | 33 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.18% in the last 52 weeks. The beta is 0.63, so Locus Cell's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -8.18% |
| 50-Day Moving Average | 20.73 |
| 200-Day Moving Average | 25.31 |
| Relative Strength Index (RSI) | 61.38 |
| Average Volume (20 Days) | 359,539 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Locus Cell had revenue of TWD 1.04 million and -109.33 million in losses. Loss per share was -0.55.
| Revenue | 1.04M |
| Gross Profit | 387,000 |
| Operating Income | -155.39M |
| Pretax Income | -109.33M |
| Net Income | -109.33M |
| EBITDA | -149.01M |
| EBIT | -155.39M |
| Loss Per Share | -0.55 |
Balance Sheet
The company has 1.42 billion in cash and 71.00 million in debt, giving a net cash position of 1.35 billion or 6.74 per share.
| Cash & Cash Equivalents | 1.42B |
| Total Debt | 71.00M |
| Net Cash | 1.35B |
| Net Cash Per Share | 6.74 |
| Equity (Book Value) | 1.78B |
| Book Value Per Share | 8.89 |
| Working Capital | 1.37B |
Cash Flow
In the last 12 months, operating cash flow was -87.82 million and capital expenditures -308.50 million, giving a free cash flow of -396.32 million.
| Operating Cash Flow | -87.82M |
| Capital Expenditures | -308.50M |
| Free Cash Flow | -396.32M |
| FCF Per Share | -1.98 |
Margins
| Gross Margin | 37.21% |
| Operating Margin | -14,941.73% |
| Pretax Margin | -10,512.40% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Locus Cell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.34% |
| FCF Yield | -8.49% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Locus Cell has an Altman Z-Score of 26.32.
| Altman Z-Score | 26.32 |
| Piotroski F-Score | n/a |